$299 Million is the total value of Birchview Capital, LP's 100 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 2.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL-MYERS SQUIBB CO | $95,788,000 | +105.6% | 1,588,772 | +100.5% | 32.00% | +13.6% |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $46,772,000 | +40.6% | 4,387,590 | +100.0% | 15.62% | -22.3% |
| QDEL | Buy | QUIDEL CORP | $25,730,000 | +125.7% | 117,288 | +130.2% | 8.60% | +24.8% |
| AWH | Buy | ASPIRA WOMENS HEALTH INC | $19,028,000 | +50.3% | 6,180,208 | +87.4% | 6.36% | -16.9% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $15,000,000 | +57.6% | 156,000 | +100.0% | 5.01% | -12.9% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $8,416,000 | +86.7% | 204,000 | +119.4% | 2.81% | +3.2% |
| BLUE | Buy | BLUEBIRD BIO INC | $6,474,000 | +76.8% | 120,000 | +100.0% | 2.16% | -2.3% |
| BIIB | Buy | BIOGEN INC | $6,240,000 | +112.0% | 22,000 | +100.0% | 2.08% | +17.2% |
| BMYRT | Buy | BMY CVR RTS 03/31/21right | $5,430,000 | +114.5% | 1,914,196 | +170.8% | 1.81% | +18.6% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $4,906,000 | +54.2% | 336,000 | +100.0% | 1.64% | -14.8% |
| XLRN | Buy | ACCELERON PHARMA INC | $4,202,000 | +136.2% | 37,344 | +100.0% | 1.40% | +30.6% |
| SLNO | Buy | SOLENO THERAPEUTICS INC | $4,152,000 | +126.1% | 1,653,798 | +100.0% | 1.39% | +25.0% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $3,986,000 | +80.0% | 340,606 | +100.0% | 1.33% | -0.4% |
| ALBO | Buy | ALBIREO PHARMA INC | $3,870,000 | +204.2% | 116,000 | +141.7% | 1.29% | +68.1% |
| MASI | Buy | MASIMO CORP | $3,776,000 | +107.0% | 16,000 | +100.0% | 1.26% | +14.4% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $3,636,000 | +66.9% | 36,000 | +100.0% | 1.22% | -7.7% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $3,290,000 | +137.5% | 44,000 | +100.0% | 1.10% | +31.3% |
| CCXI | Buy | CHEMOCENTRYX INC | $3,288,000 | +90.5% | 60,000 | +100.0% | 1.10% | +5.3% |
| MYOK | Buy | MYOKARDIA INC | $2,726,000 | +182.2% | 20,000 | +100.0% | 0.91% | +56.0% |
| CFRX | Buy | CONTRAFECT CORP | $2,700,000 | +65.2% | 511,400 | +100.0% | 0.90% | -8.7% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $2,526,000 | +40.4% | 600,000 | +130.8% | 0.84% | -22.4% |
| ETRN | Buy | EQUITRANS MIDSTREAM CORPORATIO | $2,252,000 | +103.6% | 266,100 | +100.0% | 0.75% | +12.6% |
| HROW | Buy | HARROW HEALTH INC | $2,012,000 | +114.5% | 360,000 | +100.0% | 0.67% | +18.5% |
| CORT | Buy | CORCEPT THERAPEUTICS INC | $1,740,000 | +106.9% | 100,000 | +100.0% | 0.58% | +14.4% |
| EPZM | Buy | EPIZYME INC | $1,670,000 | +48.6% | 140,000 | +100.0% | 0.56% | -17.8% |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $1,546,000 | +69.0% | 160,000 | +100.0% | 0.52% | -6.7% |
| IMGN | Buy | IMMUNOGEN INC | $1,368,000 | +56.5% | 380,000 | +100.0% | 0.46% | -13.4% |
| STOK | Buy | STOKE THERAPEUTICS INC | $1,340,000 | +180.9% | 40,000 | +100.0% | 0.45% | +55.6% |
| BHVN | Buy | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | $1,300,000 | +77.8% | 20,000 | +100.0% | 0.43% | -1.8% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $1,074,000 | +87.4% | 76,000 | +100.0% | 0.36% | +3.8% |
| NARI | Buy | INARI MEDICAL INC | $966,000 | +99.6% | 14,000 | +40.0% | 0.32% | +10.2% |
| XNCR | Buy | XENCOR INC | $954,000 | +139.7% | 24,600 | +100.0% | 0.32% | +32.4% |
| CLR | Buy | CONTINENTAL RESOURCES INC | $948,000 | +40.0% | 77,200 | +100.0% | 0.32% | -22.5% |
| GTHX | Buy | G1 THERAPEUTICS INC | $924,000 | -4.7% | 80,000 | +100.0% | 0.31% | -47.3% |
| PGNY | Buy | PROGYNY INC | $882,000 | +127.9% | 30,000 | +100.0% | 0.30% | +26.1% |
| TBIO | Buy | TRANSLATE BIO INC | $816,000 | +51.7% | 60,000 | +100.0% | 0.27% | -16.0% |
| TGTX | Buy | TG THERAPEUTICS INC | $802,000 | +174.7% | 30,000 | +100.0% | 0.27% | +52.3% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $756,000 | +108.3% | 60,000 | +100.0% | 0.25% | +15.5% |
| ARVN | Buy | ARVINAS INC | $708,000 | +40.8% | 30,000 | +100.0% | 0.24% | -22.0% |
| ICPT | Buy | INTERCEPT PHARMACEUTICALS INC | $688,000 | +72.9% | 16,600 | +100.0% | 0.23% | -4.6% |
| PXD | Buy | PIONEER NATURAL RESOURCES CO | $654,000 | +76.3% | 7,600 | +100.0% | 0.22% | -2.7% |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $640,000 | +68.9% | 60,000 | +100.0% | 0.21% | -6.6% |
| IFRX | Buy | INFLARX NV | $596,000 | +85.7% | 140,000 | +100.0% | 0.20% | +2.6% |
| OVV | Buy | OVINTIV INC | $560,000 | +70.7% | 68,700 | +100.0% | 0.19% | -5.6% |
| ODT | Buy | ODONATE THERAPEUTICS INC | $538,000 | -36.5% | 40,000 | +100.0% | 0.18% | -64.8% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $482,000 | +84.7% | 16,000 | +100.0% | 0.16% | +1.9% |
| WKHS | Buy | WORKHORSE GROUP INC | $404,000 | +54.8% | 16,000 | +6.7% | 0.14% | -14.6% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $360,000 | +41.7% | 20,000 | +100.0% | 0.12% | -22.1% |
| YTEN | Buy | YIELD10 BIOSCIENCE INC | $294,000 | +149.2% | 37,904 | +100.0% | 0.10% | +38.0% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $138,000 | +45.3% | 40,000 | +100.0% | 0.05% | -19.3% |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -10,000 | -100.0% | -0.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
| QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
| MASIMO CORP | 36 | Q3 2023 | 2.2% |
| PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
| XENCOR INC | 35 | Q3 2023 | 0.4% |
| NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
| CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
| BIOGEN INC | 31 | Q2 2022 | 3.1% |
| CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
| YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
| YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
| HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
| METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3/A | 2024-02-20 |
| 4/A | 2024-02-20 |
| SC 13G/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-04-07 |
| 4 | 2023-03-27 |
| 3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.